Reversible covalent direct thrombin inhibitors.

Por Mohanram Sivaraja, Nicola Pozzi, Matthew Rienzo, Kenneth Lin, Timothy P Shiau, Daniel M Clemens, Lev Igoudin, Piotr Zalicki, Stephanie S Chang, M Angels Estiarte, Kevin M Short, David C Williams, Anirban Datta, Enrico Di Cera, David B Kita
Publicado em 2018-01-01